IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ILYA KAPLAN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1184720138
CMS profile
53993
Location
BRONX, NY

General Payments · PY2018–2024

$19,432.13

  • Reported across 358 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,036.21

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Cardiovascular Disease NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,036.21 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $231.13 15
Edwards Lifesciences Corporation $153.24 4
Acerta Pharma LLC $139.33 7
Merck Sharp & Dohme Corporation $102.76 5
Janssen Pharmaceuticals, Inc $95.88 6
Kiniksa Pharmaceuticals International, plc $79.45 3
Amgen Inc. $69.34 3
Actelion Pharmaceuticals US, Inc. $65.94 3
PFIZER INC. $57.89 3
E.R. Squibb & Sons, L.L.C. $24.47 1
SCPHARMACEUTICALS INC. $16.78 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,351.62 82
PY2019 $5,654.67 68
PY2020 $602.74 29
PY2021 $839.71 43
PY2022 $1,072.91 47
PY2023 $874.27 38
PY2024 $1,036.21 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $10.45 01/24/2024 Food and Beverage Undisputed 01/23/2026 1078902879 CMS
Actelion Pharmaceuticals US, Inc. $27.19 04/09/2024 Food and Beverage Undisputed 01/23/2026 1078902767 CMS
Actelion Pharmaceuticals US, Inc. $28.30 11/12/2024 Food and Beverage Undisputed 01/23/2026 1078902875 CMS
Amgen Inc. $22.63 03/26/2024 Food and Beverage Undisputed 01/23/2026 1111614375 CMS
Amgen Inc. $26.84 05/29/2024 Food and Beverage Undisputed 01/23/2026 1111614377 CMS
Amgen Inc. $19.87 08/06/2024 Food and Beverage Undisputed 01/23/2026 1111614379 CMS
AstraZeneca Pharmaceuticals LP $22.43 01/16/2024 Food and Beverage Undisputed 01/23/2026 1105889589 CMS
AstraZeneca Pharmaceuticals LP $18.29 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105292489 CMS
AstraZeneca Pharmaceuticals LP $23.32 03/15/2024 Food and Beverage Undisputed 01/23/2026 1105836041 CMS
AstraZeneca Pharmaceuticals LP $19.67 04/10/2024 Food and Beverage Undisputed 01/23/2026 1104334492 CMS
AstraZeneca Pharmaceuticals LP $19.96 05/07/2024 Food and Beverage Undisputed 01/23/2026 1104623018 CMS
AstraZeneca Pharmaceuticals LP $18.32 07/19/2024 Food and Beverage Undisputed 01/23/2026 1104412137 CMS
AstraZeneca Pharmaceuticals LP $17.34 11/21/2024 Food and Beverage Undisputed 01/23/2026 1104615632 CMS
E.R. Squibb & Sons, L.L.C. $24.47 10/29/2024 Food and Beverage Undisputed 01/23/2026 1101254106 CMS
Edwards Lifesciences Corporation $33.81 03/27/2024 Food and Beverage Undisputed 01/23/2026 1138885959 CMS
Edwards Lifesciences Corporation $45.05 07/17/2024 Food and Beverage Undisputed 01/23/2026 1138885979 CMS
Edwards Lifesciences Corporation $44.53 07/23/2024 Food and Beverage Undisputed 01/23/2026 1138885985 CMS
Edwards Lifesciences Corporation $29.85 11/06/2024 Food and Beverage Undisputed 01/23/2026 1138885991 CMS
Janssen Pharmaceuticals, Inc $22.52 01/31/2024 Food and Beverage Undisputed 01/23/2026 1078104152 CMS
Janssen Pharmaceuticals, Inc $2.67 01/31/2024 Food and Beverage Undisputed 01/23/2026 1078104910 CMS
Janssen Pharmaceuticals, Inc $4.35 05/02/2024 Food and Beverage Undisputed 01/23/2026 1078104342 CMS
Janssen Pharmaceuticals, Inc $27.12 05/02/2024 Food and Beverage Undisputed 01/23/2026 1078104720 CMS
Janssen Pharmaceuticals, Inc $20.47 07/25/2024 Food and Beverage Undisputed 01/23/2026 1078104398 CMS
Janssen Pharmaceuticals, Inc $18.75 08/27/2024 Food and Beverage Undisputed 01/23/2026 1078104452 CMS
Kiniksa Pharmaceuticals International, plc $25.94 03/20/2024 Food and Beverage Undisputed 01/23/2026 1154876945 CMS
Kiniksa Pharmaceuticals International, plc $23.71 07/31/2024 Food and Beverage Undisputed 01/23/2026 1154876999 CMS
Kiniksa Pharmaceuticals International, plc $29.80 11/20/2024 Food and Beverage Undisputed 01/23/2026 1154877019 CMS
Merck Sharp & Dohme LLC $21.43 04/03/2024 Food and Beverage Undisputed 01/23/2026 1141706566 CMS
Merck Sharp & Dohme LLC $17.42 06/21/2024 Food and Beverage Undisputed 01/23/2026 1141872311 CMS
Merck Sharp & Dohme LLC $23.27 08/19/2024 Food and Beverage Undisputed 01/23/2026 1141706564 CMS
Merck Sharp & Dohme LLC $17.77 10/09/2024 Food and Beverage Undisputed 01/23/2026 1141930443 CMS
Merck Sharp & Dohme LLC $22.87 11/05/2024 Food and Beverage Undisputed 01/23/2026 1141706562 CMS
Novartis Pharmaceuticals Corporation $26.82 01/23/2024 Food and Beverage Undisputed 01/23/2026 1087006378 CMS
Novartis Pharmaceuticals Corporation $14.52 03/05/2024 Food and Beverage Undisputed 01/23/2026 1087006380 CMS
Novartis Pharmaceuticals Corporation $1.42 04/16/2024 Food and Beverage Undisputed 01/23/2026 1087006388 CMS
Novartis Pharmaceuticals Corporation $22.36 04/16/2024 Food and Beverage Undisputed 01/23/2026 1087006390 CMS
Novartis Pharmaceuticals Corporation $20.92 05/08/2024 Food and Beverage Undisputed 01/23/2026 1087006386 CMS
Novartis Pharmaceuticals Corporation $28.63 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087006382 CMS
Novartis Pharmaceuticals Corporation $12.67 07/03/2024 Food and Beverage Undisputed 01/23/2026 1087006392 CMS
Novartis Pharmaceuticals Corporation $1.37 07/03/2024 Food and Beverage Undisputed 01/23/2026 1087006396 CMS
Novartis Pharmaceuticals Corporation $10.07 07/10/2024 Food and Beverage Undisputed 01/23/2026 1087006384 CMS
Novartis Pharmaceuticals Corporation $1.37 08/05/2024 Food and Beverage Undisputed 01/23/2026 1087006394 CMS
Novartis Pharmaceuticals Corporation $15.09 08/05/2024 Food and Beverage Undisputed 01/23/2026 1087006398 CMS
Novartis Pharmaceuticals Corporation $22.30 09/18/2024 Food and Beverage Undisputed 01/23/2026 1087006400 CMS
Novartis Pharmaceuticals Corporation $14.31 10/29/2024 Food and Beverage Undisputed 01/23/2026 1087006404 CMS
Novartis Pharmaceuticals Corporation $16.83 10/30/2024 Food and Beverage Undisputed 01/23/2026 1087006402 CMS
Novartis Pharmaceuticals Corporation $22.45 12/17/2024 Food and Beverage Undisputed 01/23/2026 1087006406 CMS
PFIZER INC. $15.55 02/07/2024 Food and Beverage Undisputed 01/23/2026 1131042011 CMS
PFIZER INC. $19.91 04/17/2024 Food and Beverage Undisputed 01/23/2026 1131320862 CMS
PFIZER INC. $22.43 09/25/2024 Food and Beverage Undisputed 01/23/2026 1131944814 CMS
SCPHARMACEUTICALS INC. $16.78 08/13/2024 Food and Beverage Undisputed 01/23/2026 1132293068 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.